Skip to content

Role of Mesh in Laparoscopic Sacropexy Surgical Techniques for the Treatment of Female Genital Prolapse

Role of Mesh in Laparoscopic Sacropexy Surgical Techniques for the Treatment of Female Genital Prolapse

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06720831
Enrollment
160
Registered
2024-12-06
Start date
2024-12-31
Completion date
2025-03-31
Last updated
2024-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Genital Prolapse

Keywords

prolapse, female genital, gynaecology, sacropexy, mesh

Brief summary

This study aims to determine the rate of recurrence of central pelvic organ prolapse in patients who have undergone surgery (sacropexy with and without mesh) for the same pathology.

Detailed description

There is a lack of data in the literature comparing sacroplexing with the use of mesh with sacroplexing performed without the use of mesh in terms of recurrence, improvement in symptoms, and restoration of normal pelvic organ prolapse relationships. The objective of this study is to determine the rate of recurrence of central pelvic organ prolapse in patients with a clinical diagnosis of genital prolapse stage ≥ 2 according to the POP-Q classification who underwent laparoscopic sacroplasty with mesh (group 1) and without mesh (group 2). The study may provide information on the impact of mesh in laparoscopic surgery for the correction of central pelvic organ prolapse.

Interventions

None listed

Sponsors

IRCCS Azienda Ospedaliero-Universitaria di Bologna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Clinical diagnosis of genital prolapse stage ≥ 2 according to POP-Q classification * Surgical treatment of laparoscopic sacropexy by mesh (group 1) and without (group 2) in female patients * Acquisition of informed consent * At least one follow-up evaluation at 24 months

Exclusion criteria

* Age \> 80 years * Previous genital prolapse surgery

Design outcomes

Primary

MeasureTime frameDescription
Recurrence rate of central pelvic organ prolapse24 months after surgeryThe rate of recurrence of central pelvic organ prolapse in patients with a clinical diagnosis of genital prolapse stage ≥ 2 according to the POP-Q classification, undergoing sacroplasty with and without mesh

Secondary

MeasureTime frameDescription
Recurrence rate of central pelvic organ prolapse in laparoscopic sacral hysteropexy, sacralcervicopexy and sacralcolpopexy24 months after surgeryThe rate of pelvic organ prolapse recurrence in patients treated with mesh (group 1) and without (group 2) in the laparoscopic sacral hysteropexy, sacralcervicopexy and sacralcolpopexy
Rate of intraoperative and postoperative complicationsDuring surgery and within 30 daysEvaluation of intraoperative and postoperative complications according to the Clavien-Dindo classification
Modification of symptoms after surgeryBefore surgery and 24 months after surgeryChange in pre- and post-operative symptomatology assessed through the completion of a questionnaire
Changes in the disease frameworkBefore surgery and 24 months after surgeryChange in the disease framework of pelvic organ prolapse according to the POP-Q classification assessed before and after surgery

Countries

Italy

Contacts

Primary ContactDiego Raimondo, MD
die.raimondo@gmail.com+393290636618
Backup ContactManuela Maletta, MD
manuela.maletta@studio.unibo.it

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026